Engineered ACE2 receptor therapy overcomes mutational escape of SARS-CoV-2
Sign Up to like & getrecommendations! Published in 2021 at "Nature Communications"
DOI: 10.1038/s41467-021-24013-y
Abstract: SARS-CoV-2 has mutated during the global pandemic leading to viral adaptation to medications and vaccinations. Here we describe an engineered human virus receptor, ACE2, by mutagenesis and screening for binding to the receptor binding domain… read more here.
Keywords: escape; ace2 receptor; receptor therapy; sars cov ... See more keywords